{"id":"https://openalex.org/W2045793565","doi":"https://doi.org/10.1007/s40263-014-0193-z","title":"Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder","display_name":"Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder","alternate_titles":[],"publication_year":2014,"publication_date":"2014-08-19","ids":{"openalex":"https://openalex.org/W2045793565","doi":"https://doi.org/10.1007/s40263-014-0193-z","mag":"2045793565","pmid":"https://pubmed.ncbi.nlm.nih.gov/25139785","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4246127"},"language":"en","primary_location":{"id":"doi:10.1007/s40263-014-0193-z","doi":"https://doi.org/10.1007/s40263-014-0193-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40263-014-0193-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40263-014-0193-z.pdf","source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2045793565"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40263-014-0193-z.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016008616","display_name":"Tobias Banaschewski","orcid":"https://orcid.org/0000-0003-4595-1144","observed_orcids":["https://orcid.org/0000-0003-4595-1144"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4210105615","display_name":"Central Institute of Mental Health","ror":"https://ror.org/01hynnt93","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210105615"]},{"id":"https://openalex.org/I4387153978","display_name":"Medizinische Fakult\u00e4t Mannheim","ror":"https://ror.org/02m1z0a87","country_code":"DE","type":"education","lineage":["https://openalex.org/I4387153978"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Tobias Banaschewski","raw_affiliation_strings":["Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, P.O. Box: 12 21 20, 68072, Mannheim, Germany, tobias.banaschewski@zi-mannheim.de","University of Heidelberg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, P.O. Box: 12 21 20, 68072, Mannheim, Germany, tobias.banaschewski@zi-mannheim.de","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210105615","https://openalex.org/I4387153978"]},{"raw_affiliation_string":"University of Heidelberg","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070385935","display_name":"Mats Johnson","orcid":"https://orcid.org/0000-0001-5195-3379","observed_orcids":["https://orcid.org/0000-0001-5195-3379"]},"institutions":[{"id":"https://openalex.org/I4210100555","display_name":"Drottning Silvias barn- och ungdomssjukhus","ror":"https://ror.org/00yqpgp96","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325","https://openalex.org/I4210100555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Mats Johnson","raw_affiliation_strings":["Child Neuropsychiatry Unit, Queen Silvia Children\u2019s Hospital, Gothenburg, Sweden","Queen Silvia Children's Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Child Neuropsychiatry Unit, Queen Silvia Children\u2019s Hospital, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210100555"]},{"raw_affiliation_string":"Queen Silvia Children's Hospital","institution_ids":["https://openalex.org/I4210100555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044193621","display_name":"Michel Lecendreux","orcid":"https://orcid.org/0000-0003-4409-2931","observed_orcids":["https://orcid.org/0000-0003-4409-2931"]},"institutions":[{"id":"https://openalex.org/I4210126712","display_name":"H\u00f4pital Robert-Debr\u00e9","ror":"https://ror.org/02dcqy320","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210126712"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Michel Lecendreux","raw_affiliation_strings":["Paediatric Sleep Centre and National Reference Centre for Orphan Diseases: Narcolepsy, Idiopathic Hypersomnia and Kleine\u2013Levin Syndrome, Robert-Debr\u00e9 University Hospital, Paris, France","Robert-Debr\u00e9 University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paediatric Sleep Centre and National Reference Centre for Orphan Diseases: Narcolepsy, Idiopathic Hypersomnia and Kleine\u2013Levin Syndrome, Robert-Debr\u00e9 University Hospital, Paris, France","institution_ids":["https://openalex.org/I4210126712"]},{"raw_affiliation_string":"Robert-Debr\u00e9 University Hospital","institution_ids":["https://openalex.org/I4210126712"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052792299","display_name":"Alessandro Zuddas","orcid":"https://orcid.org/0000-0002-4409-0680","observed_orcids":["https://orcid.org/0000-0002-4409-0680"]},"institutions":[{"id":"https://openalex.org/I172446870","display_name":"University of Cagliari","ror":"https://ror.org/003109y17","country_code":"IT","type":"education","lineage":["https://openalex.org/I172446870"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessandro Zuddas","raw_affiliation_strings":["Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy","University of Cagliari;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy","institution_ids":["https://openalex.org/I172446870"]},{"raw_affiliation_string":"University of Cagliari;","institution_ids":["https://openalex.org/I172446870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064064053","display_name":"Ben A. Adeyi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ben Adeyi","raw_affiliation_strings":["Shire, Wayne, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire, Wayne, PA, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113890775","display_name":"Paul Hodgkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]},{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Hodgkins","raw_affiliation_strings":["Shire, Wayne, PA, USA","Vertex Pharmaceuticals"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire, Wayne, PA, USA","institution_ids":["https://openalex.org/I4210140176"]},{"raw_affiliation_string":"Vertex Pharmaceuticals","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039645834","display_name":"Liza A. Squires","orcid":"https://orcid.org/0009-0004-6886-0020","observed_orcids":["https://orcid.org/0009-0004-6886-0020"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liza A. Squires","raw_affiliation_strings":["Shire, Wayne, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire, Wayne, PA, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076676344","display_name":"David Coghill","orcid":"https://orcid.org/0000-0003-3017-9737","observed_orcids":["https://orcid.org/0000-0003-3017-9737"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David R. Coghill","raw_affiliation_strings":["Division of Neuroscience, University of Dundee, Dundee, UK","University of Dundee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neuroscience, University of Dundee, Dundee, UK","institution_ids":["https://openalex.org/I177639307"]},{"raw_affiliation_string":"University of Dundee","institution_ids":["https://openalex.org/I177639307"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5016008616"],"corresponding_institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210105615","https://openalex.org/I4387153978"],"apc_list":{"value":5090,"currency":"USD","value_usd":5090},"apc_paid":{"value":5090,"currency":"USD","value_usd":5090},"fwci":3.3212,"has_fulltext":true,"cited_by_count":53,"citation_normalized_percentile":{"value":0.91435243,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"28","issue":"12","first_page":"1191","last_page":"1203"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lisdexamfetamine-dimesylate","display_name":"lisdexamfetamine dimesylate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9900000095367432},{"id":"https://openalex.org/keywords/children-and-adolescents","display_name":"children and adolescents","score":0.8289999961853027},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.8820000290870667},{"id":"https://openalex.org/keywords/functional-disability","display_name":"functional disability","score":0.9950000047683716},{"id":"https://openalex.org/keywords/weiss-functional-impairment-rating-scale","display_name":"Weiss Functional Impairment Rating Scale","score":0.9599999785423279},{"id":"https://openalex.org/keywords/parent-reported-outcomes","display_name":"parent-reported outcomes","score":0.5550000071525574},{"id":"https://openalex.org/keywords/adhd-symptoms","display_name":"ADHD symptoms","score":0.3240000009536743},{"id":"https://openalex.org/keywords/efficacy-and-tolerability","display_name":"treatment efficacy and tolerability","score":0.4300000071525574}],"concepts":[{"id":"https://openalex.org/C103709681","wikidata":"https://www.wikidata.org/wiki/Q1515727","display_name":"Psychopharmacology","level":2,"score":0.6352394819259644},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.6317054629325867},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.5792751312255859},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5693420171737671},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5244781374931335},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.48359936475753784},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.48328664898872375},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4731001853942871},{"id":"https://openalex.org/C3019006561","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Health related quality of life","level":3,"score":0.42757388949394226},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4180728793144226},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.16128656268119812},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13933289051055908},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069478","descriptor_name":"Lisdexamfetamine Dimesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003913","descriptor_name":"Dextroamphetamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003913","descriptor_name":"Dextroamphetamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":8,"locations":[{"id":"doi:10.1007/s40263-014-0193-z","doi":"https://doi.org/10.1007/s40263-014-0193-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40263-014-0193-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40263-014-0193-z.pdf","source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3221614","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4246127","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:25139785","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25139785","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS drugs","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:discovery.dundee.ac.uk:openaire_cris_publications/ba6d6df0-e878-4fa6-826b-a3e2f5cfcb77","doi":null,"is_oa":false,"landing_page_url":"https://discovery.dundee.ac.uk/en/publications/ba6d6df0-e878-4fa6-826b-a3e2f5cfcb77","pdf_url":null,"source":{"id":"https://openalex.org/S4306400523","display_name":"Discovery Research Portal (University of Dundee)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177639307","host_organization_name":"University of Dundee","host_organization_lineage":["https://openalex.org/I177639307"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Banaschewski, T, Johnson, M, Lecendreux, M, Zuddas, A, Adeyi, B, Hodgkins, P, Squires, L A & Coghill, D R 2014, 'Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder', CNS Drugs, vol. 28, no. 12, pp. 1191-1203. https://doi.org/10.1007/s40263-014-0193-z","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4246127","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4246127/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"Text"},{"id":"pmh:oai:iris.unica.it:11584/57314","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11584/57314","pdf_url":null,"source":{"id":"https://openalex.org/S4377196293","display_name":"UNICA IRIS Institutional Research Information System (University of Cagliari)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I172446870","host_organization_name":"University of Cagliari","host_organization_lineage":["https://openalex.org/I172446870"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:jupiter.its.unimelb.edu.au:11343/221185","doi":null,"is_oa":true,"landing_page_url":"http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345636300007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4d813f4571fa7d6246bdc0dfeca3a1c","pdf_url":null,"source":{"id":"https://openalex.org/S4377196259","display_name":"Minerva Access (University of Melbourne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I165779595","host_organization_name":"The University of Melbourne","host_organization_lineage":["https://openalex.org/I165779595"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.778.5121","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.778.5121","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/1b/ca/40263_2014_Article_193.PMC4246127.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1007/s40263-014-0193-z","doi":"https://doi.org/10.1007/s40263-014-0193-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40263-014-0193-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40263-014-0193-z.pdf","source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320312517","display_name":"Vertex Pharmaceuticals","ror":"https://ror.org/00anb1726"},{"id":"https://openalex.org/F4320320290","display_name":"University of Oxford","ror":"https://ror.org/052gg0110"},{"id":"https://openalex.org/F4320323906","display_name":"Vifor Pharma","ror":"https://ror.org/0185z7g17"},{"id":"https://openalex.org/F4320327918","display_name":"H. Lundbeck A/S","ror":"https://ror.org/0564cd633"},{"id":"https://openalex.org/F4320338413","display_name":"Cilag","ror":"https://ror.org/02fe4h741"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2045793565.pdf","grobid_xml":"https://content.openalex.org/works/W2045793565.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W25938887","https://openalex.org/W1971838314","https://openalex.org/W1973439065","https://openalex.org/W1974896478","https://openalex.org/W1979206088","https://openalex.org/W1989444430","https://openalex.org/W1993327116","https://openalex.org/W1999725272","https://openalex.org/W2023262882","https://openalex.org/W2028637191","https://openalex.org/W2037557484","https://openalex.org/W2041139943","https://openalex.org/W2042644970","https://openalex.org/W2066865689","https://openalex.org/W2080680950","https://openalex.org/W2083388738","https://openalex.org/W2085942575","https://openalex.org/W2086997214","https://openalex.org/W2090672792","https://openalex.org/W2105411076","https://openalex.org/W2117267641","https://openalex.org/W2127512142","https://openalex.org/W2129620184","https://openalex.org/W2131679908","https://openalex.org/W2150988818","https://openalex.org/W2159011576","https://openalex.org/W2163817145","https://openalex.org/W2168895300","https://openalex.org/W3177640887","https://openalex.org/W4247665917","https://openalex.org/W6836258609"],"related_works":["https://openalex.org/W2041139943","https://openalex.org/W2028637191","https://openalex.org/W1994248325","https://openalex.org/W2610912354","https://openalex.org/W76668800","https://openalex.org/W215407455","https://openalex.org/W2129620184","https://openalex.org/W2047067115","https://openalex.org/W2996557655"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,228,273],"stimulant":[2],"prodrug":[3],"lisdexamfetamine":[4],"dimesylate":[5],"(LDX)":[6],"is":[7,63],"an":[8,165],"effective":[9],"and":[10,31,49,81,101,111,120,138,158,201,208,214,218,266,275,282,315,377,394,397,403,448,450,454,483,493],"generally":[11],"well":[12,59],"tolerated":[13],"treatment":[14,168,491],"for":[15,191,269],"the":[16,88,108,121,154,211,221,236,245,306,312,328,332,344,350,356,363,391,395,415,419,426,432,438,445,470],"symptoms":[17],"of":[18,24,29,54,67,70,75,91,93,99,147,170,184,210,220,230,311,327,358,414,440,469,473,478,481,490],"attention-deficit/hyperactivity":[19],"disorder":[20],"(ADHD).":[21],"Positive":[22],"impacts":[23],"LDX":[25,94,167,185,351,359,433,441,474],"on":[26,180],"health-related":[27,97,479],"quality":[28,98,480],"life":[30,100,482],"functional":[32,103,484],"impairment":[33,485],"have":[34],"previously":[35],"been":[36],"demonstrated":[37,487],"in":[38,47,51,79,95,250,309,340,343,349,362,390,405,425,431,444,455,475],"a":[39,64,139,192],"7-week,":[40],"randomized,":[41,496],"double-blind,":[42,194,497],"placebo-controlled,":[43],"phase":[44],"III":[45],"study":[46,78,157],"children":[48,80],"adolescents":[50,82],"Europe.":[52],"Maintenance":[53],"these":[55],"broad":[56],"benefits,":[57],"as":[58,60,105,235],"symptomatic":[61],"control,":[62],"key":[65],"goal":[66],"long-term":[68,89,467],"management":[69],"ADHD.":[71],"OBJECTIVE:":[72],"Secondary":[73],"objectives":[74],"this":[76],"multinational":[77],"with":[83,135,239,354,436],"ADHD":[84,137,141],"were":[85,151,175,244,264,299,388],"to":[86,178,187,189,256,325,412],"assess":[87],"maintenance":[90,468],"effectiveness":[92],"improving":[96],"reducing":[102],"impairment,":[104],"gauged":[106],"using":[107],"Child":[109],"Health":[110],"Illness":[112],"Profile-Child":[113],"Edition:":[114],"Parent":[115],"Report":[116,127],"Form":[117],"(CHIP-CE:":[118],"PRF)":[119],"Weiss":[122],"Functional":[123],"Impairment":[124],"Rating":[125,142],"Scale-Parent":[126],"(WFIRS-P),":[128],"respectively.":[129,293],"METHODS:":[130],"Patients":[131,162],"aged":[132],"6-17":[133],"years":[134],"diagnosed":[136],"baseline":[140,255,324,411],"Scale":[143],"IV":[144],"total":[145,401,456],"score":[146,402],"at":[148,171,204,215,225],"least":[149,172],"28":[150],"enrolled":[152],"from":[153,159,254,323,410],"previous":[155],"European":[156],"US":[160],"sites.":[161],"who":[163],"completed":[164,198],"open-label":[166,212,274,329,416],"period":[169,213,232],"26":[173,209],"weeks":[174,205,216],"randomized":[176,276],"(1:1)":[177],"continue":[179],"their":[181],"optimized":[182],"dose":[183],"or":[186,224],"switch":[188],"placebo":[190,288,345,427],"6-week,":[193],"withdrawal":[195,494],"period.":[196,330,417],"Parents":[197],"CHIP-CE:":[199,296,336],"PRF":[200,297,337],"WFIRS-P":[202,386,400],"questionnaires":[203],"0,":[206],"8":[207],"0":[217],"6":[219],"randomized-withdrawal":[222,333,420],"period,":[223,334,421],"early":[226],"termination.":[227],"endpoint":[229,257,326,413],"each":[231],"was":[233,317,360,442,486],"defined":[234],"last":[237],"visit":[238],"valid":[240],"data.":[241],"Effect":[242],"sizes":[243],"difference":[246],"(LDX":[247,284],"minus":[248],"placebo)":[249],"least-squares":[251],"(LS)-mean":[252],"change":[253],"divided":[258],"by":[259,488],"root-mean-square":[260],"error.":[261],"P":[262],"values":[263],"nominal":[265],"not":[267,348,430],"adjusted":[268],"multiple":[270,476],"comparisons.":[271],"RESULTS:":[272],"full":[277],"analysis":[278],"sets":[279],"comprised":[280],"262":[281],"153":[283],"n":[285,289],"=":[286,290],"76;":[287],"77)":[291],"patients,":[292],"Mean":[294,384],"pretreatment":[295,385],"T-scores":[298,338],"more":[300],"than":[301],"one":[302],"standard":[303],"deviation":[304],"below":[305],"normative":[307],"mean":[308],"four":[310],"five":[313],"domains,":[314],"there":[316],"significant":[318,361,443],"improvement":[319],"across":[320],"all":[321,341,406],"domains":[322,342,407,453,477],"In":[331,418],"LS-mean":[335,422],"deteriorated":[339,424],"group,":[346],"but":[347,429],"group.":[352,434],"Compared":[353,435],"placebo,":[355,437],"effect":[357,439,472],"Risk":[364],"Avoidance":[365],"(effect":[366,457],"size":[367,458],"0.829;":[368],"p":[369,374,380,460],"<":[370,375,381,461],"0.001),":[371],"Achievement":[372],"(0.696;":[373],"0.001)":[376,382],"Satisfaction":[378],"(0.636;":[379],"domains.":[383],"scores":[387,404,423],"lowest":[389],"Family":[392],"domain":[393],"Learning":[396,447],"School":[398],"domain.":[399],"improved":[408],"significantly":[409],"group":[428],"Family,":[446],"School,":[449],"Risky":[451],"Activities":[452],"0.908;":[459],"0.001).":[462],"CONCLUSIONS:":[463],"Using":[464],"parent-rated":[465],"instruments,":[466],"beneficial":[471],"comparison":[489],"continuation":[492],"under":[495],"placebo-controlled":[498],"conditions.":[499]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2045793565","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":8}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
